Rolf H. Günther
Geen lopende functies
Profiel
Dr. Rolf H.
Günther, MD PhD, is Chief Executive Officer at Bicycle Therapeutics Ltd.
Dr. Günther was previously employed as VP-Global Clinical Research & Development by Aventis Behring LLC and Chief Executive & Operating Officer by Affimed Therapeutics AG.
He received his doctorate degree from The Johannes Gutenberg University of Mainz.
Eerdere bekende functies van Rolf H. Günther
| Bedrijven | Functie | Einde |
|---|---|---|
Affimed NV Niederlassung Deutschland
 Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Algemeen Directeur | - |
| Aventis Behring LLC | Corporate Officer/Principal | - |
| BICYCLE THERAPEUTICS PLC | Algemeen Directeur | - |
Opleiding van Rolf H. Günther
| The Johannes Gutenberg University of Mainz | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BICYCLE THERAPEUTICS PLC | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Affimed NV Niederlassung Deutschland
Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Health Technology |
| Aventis Behring LLC |
